BMS-509744

response biomarkers — cross-omics
Drug responseDRUG → FUNCTION-SHRNACell lineKIN001-127, ITK inhibitor

Across CCLE and GDSC cell-line panels, response to BMS-509744 is significantly associated with the shRNA pathway dependency of multiple pathways, with BLOOD_Myeloma cell lines showing a particularly strong set of associations.

The most reproducible BMS-509744 response-associated pathways across cancer lineages are L-threonine metabolic process, L-threonine catabolic process, and Columnar/cuboidal epithelial cell differentiation, each associated with drug response in up to 5 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, BMS-509744 response versus L-threonine metabolic process shRNA pathway dependency in BLOOD_Myeloma (Pearson r = 0.66).

Shrna pathway dependency biomarkers of BMS-509744 response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner pathwayX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaL-threonine metabolic process →+1.424+0.412.031.00535
BLOOD_MyelomaL-threonine catabolic process →+1.424+0.412.031.00535
LUNG_NSCLC_LUADColumnar/cuboidal epithelial cell differentiation →-0.401-0.921.011.02035
LUNG_NSCLC_LUADRegulation of Golgi inheritance →+1.822+1.230<.001<.00135
CNSDNA replication →-0.396-0.692<.001.04935
CNSDNA-templated DNA replication →-0.356-0.692.001.04935
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

BMS-509744 response vs L-threonine metabolic process — BLOOD_Myeloma

Per-cell-line scatter of BMS-509744 response vs L-threonine metabolic process shRNA pathway dependency in BLOOD_Myeloma.

Explore this scatter interactively →

Exploration